Literature DB >> 4142471

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.

D P Huang, J H Ho, W Henle, G Henle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4142471     DOI: 10.1002/ijc.2910140504

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  21 in total

1.  α-Helix peptides designed from EBV-gH protein display higher antigenicity and induction of monocyte apoptosis than the native peptide.

Authors:  Mauricio Urquiza; Johanna Melo-Cardenas; Tatiana Guevara; Ignacia Echeverria; Isabel C Rodriguez; Magnolia Vanegas; Mario Amzel; Manuel E Patarroyo
Journal:  Amino Acids       Date:  2010-05-16       Impact factor: 3.520

2.  A study of Epstein Barr virus receptor activity in cell free extracts of human lymphoblastoid cells.

Authors:  M H Ng; S W Lui; K H Chan
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.

Authors:  Cheuk Wai Choi; Michael C H Lee; Wai Tong Ng; Lai Yau Law; Tsz Kok Yau; Anne W M Lee
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

4.  Detection of Epstein-Barr virus in a case of undifferentiated nasopharyngeal carcinoma by in situ hybridization with digoxigenin-labelled PCR-generated probes.

Authors:  P Delvenne; B Kaschten; J M Deneufbourg; L Demanez; A Stevenaert; M Reznik; J Boniver
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus.

Authors:  P H Levine; S A Leiseca; J F Hewetson; K A Traul; A P Andrese; D J Granlund; P Fabrizio; D A Stevens
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  Experimental studies on specific immunotherapy in nasopharyngeal carcinoma (NPC).

Authors:  W Arnold; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1980

Review 7.  Proof for EBV's sustaining role in Burkitt's lymphomas.

Authors:  David Vereide; Bill Sugden
Journal:  Semin Cancer Biol       Date:  2009-07-21       Impact factor: 15.707

8.  Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.

Authors:  Y C Cheng; J Y Chen; R Glaser; W Henle
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells.

Authors:  R Glaser; D V Ablashi; M Nonoyama; W Henle; J Easton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma.

Authors:  C K Chan; N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.